Literature DB >> 20810984

B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion.

Brandon Renner1, Derek Strassheim, Claudia R Amura, Liudmila Kulik, Danica Ljubanovic, Magdalena J Glogowska, Kazue Takahashi, Michael C Carroll, V Michael Holers, Joshua M Thurman.   

Abstract

Ischemia/reperfusion (I/R) triggers a robust inflammatory response within the kidney. Numerous components of the immune system contribute to the resultant renal injury, including the complement system. We sought to identify whether natural Abs bind to the postischemic kidney and contribute to complement activation after I/R. We depleted peritoneal B cells in mice by hypotonic shock. Depletion of the peritoneal B cells prevented the deposition of IgM within the glomeruli after renal I/R and attenuated renal injury after I/R. We found that glomerular IgM activates the classical pathway of complement, but it does not cause substantial deposition of C3 within the kidney. Furthermore, mice deficient in classical pathway proteins were not protected from injury, indicating that glomerular IgM does not cause injury through activation of the classical pathway. We also subjected mice deficient in all mature B cells (μMT mice) to renal I/R and found that they sustained worse renal injury than wild-type controls. Serum IL-10 levels were lower in the μMT mice. Taken together, these results indicate that natural Ab produced by peritoneal B cells binds within the glomerulus after renal I/R and contributes to functional renal injury. However, nonperitoneal B cells attenuate renal injury after I/R, possibly through the production of IL-10.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810984      PMCID: PMC3133676          DOI: 10.4049/jimmunol.0903239

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  B cell deficiency confers protection from renal ischemia reperfusion injury.

Authors:  Melissa J Burne-Taney; Dolores B Ascon; Frank Daniels; Lorraine Racusen; William Baldwin; Hamid Rabb
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

2.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.

Authors:  M Botto; C Dell'Agnola; A E Bygrave; E M Thompson; H T Cook; F Petry; M Loos; P P Pandolfi; M J Walport
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

3.  Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes.

Authors:  Pierce Park; Mark Haas; Patrick N Cunningham; Lihua Bao; Jessy J Alexander; Richard J Quigg
Journal:  Am J Physiol Renal Physiol       Date:  2002-02

4.  Predominant role for C5b-9 in renal ischemia/reperfusion injury.

Authors:  W Zhou; C A Farrar; K Abe; J R Pratt; J E Marsh; Y Wang; G L Stahl; S H Sacks
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

5.  Intestinal reperfusion injury is mediated by IgM and complement.

Authors:  J P Williams; T T Pechet; M R Weiser; R Reid; L Kobzik; F D Moore; M C Carroll; H B Hechtman
Journal:  J Appl Physiol (1985)       Date:  1999-03

6.  Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire.

Authors:  Sherry D Fleming; Terez Shea-Donohue; Joel M Guthridge; Liudmila Kulik; Thomas J Waldschmidt; Matthew G Gipson; George C Tsokos; V Michael Holers
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

7.  Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice.

Authors:  Joshua M Thurman; Danica Ljubanovic; Charles L Edelstein; Gary S Gilkeson; V Michael Holers
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 8.  Ischemic acute renal failure: an inflammatory disease?

Authors:  Joseph V Bonventre; Anna Zuk
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

9.  Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.

Authors:  M R Wessels; P Butko; M Ma; H B Warren; A L Lage; M C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 10.  Regulatory B cells as inhibitors of immune responses and inflammation.

Authors:  Jean-David Bouaziz; Koichi Yanaba; Thomas F Tedder
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

View more
  48 in total

Review 1.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

Review 2.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

3.  B Cells in Transplantation of Rat, Mouse, and Man.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

4.  Natural IgM anti-leukocyte autoantibodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17.

Authors:  Peter I Lobo; Amandeep Bajwa; Kailo H Schlegel; John Vengal; Sang J Lee; Liping Huang; Hong Ye; Umesh Deshmukh; Tong Wang; Hong Pei; Mark D Okusa
Journal:  J Immunol       Date:  2012-01-18       Impact factor: 5.422

5.  Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI.

Authors:  Mark D Okusa; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-30       Impact factor: 10.121

6.  Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells.

Authors:  Taishi Fang; Tai Yeon Koo; Jae-Ghi Lee; Joon Young Jang; Yixuan Xu; Ju Hee Hwang; Sunjoo Park; Ji-Jing Yan; Jung-Hwa Ryu; Yeon-Mi Ryu; Sang-Yeob Kim; Kyung-Suk Suh; Jaeseok Yang
Journal:  J Am Soc Nephrol       Date:  2019-07-11       Impact factor: 10.121

7.  Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.

Authors:  Andrew Elvington; Carl Atkinson; Liudmila Kulik; Hong Zhu; Jin Yu; Mark S Kindy; V Michael Holers; Stephen Tomlinson
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

Review 8.  Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.

Authors:  Nicholas A Zwang; Joseph R Leventhal
Journal:  J Am Soc Nephrol       Date:  2017-05-02       Impact factor: 10.121

9.  Cyclosporine induces endothelial cell release of complement-activating microparticles.

Authors:  Brandon Renner; Jelena Klawitter; Ryan Goldberg; James W McCullough; Viviana P Ferreira; James E Cooper; Uwe Christians; Joshua M Thurman
Journal:  J Am Soc Nephrol       Date:  2013-10-03       Impact factor: 10.121

10.  Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.

Authors:  Takashi Miwa; Sayaka Sato; Damodar Gullipalli; Masaomi Nangaku; Wen-Chao Song
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.